Digestive cancer research at Institut Curie

The specialists of the two sites of Institut Curie actively participate in translational and clinical research. Patients are offered a place in a clinical trial when they meet the specified requirements. Trials sometimes allow patients to be administered promising medications that are not yet on the market. The clinical trials available at Institut Curie cover all treatment methods, particularly early trials that assess immunotherapy and new targeted therapies in development. 

The characterization of genetic changes associated with cancers is playing an increasingly important role because it sometimes makes it possible to identify anomalies that can be targeted by specific treatments. Institut Curie has all the tools and platforms to implement this type of analysis. 

Several teams of the Research Center in collaboration with the clinicians of the two sites of the institute seek to decipher the fundamental mechanisms involved in the development of digestive cancers. Another major aspect of the research carried out at Institut Curie concerns the detection of tumor DNA in the blood, which offers particularly interesting prospects for monitoring patients undergoing treatment, assessing prognosis, and screening for cancers and recurrences after treatment.